Advertisement

Topics

Vaccinex raises $40M in IPO

06:38 EDT 10 Aug 2018 | SmartBrief

An initial public offering raised $40 million for Vaccinex, which has an ongoing Phase Ib/II trial of drug candidate VX15 in  -More

Original Article: Vaccinex raises $40M in IPO

NEXT ARTICLE

More From BioPortfolio on "Vaccinex raises $40M in IPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...